247 related articles for article (PubMed ID: 9571747)
1. High-level aminoglycoside-resistant enterococcus causing endocarditis successfully treated with a combination of ampicillin, imipenem and vancomycin.
Antony SJ; Ladner J; Stratton CW; Raudales F; Dummer SJ
Scand J Infect Dis; 1997; 29(6):628-30. PubMed ID: 9571747
[TBL] [Abstract][Full Text] [Related]
2. [Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations].
Pişkin N; Akduman D; Aydemir H; Celebi G; Oztoprak N; Aktaş E
Mikrobiyol Bul; 2008 Jul; 42(3):509-14. PubMed ID: 18822897
[TBL] [Abstract][Full Text] [Related]
3. Aminoglycoside resistant enterococcal endocarditis.
Eliopoulos GM
Infect Dis Clin North Am; 1993 Mar; 7(1):117-33. PubMed ID: 8463648
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance.
Kak V; Donabedian SM; Zervos MJ; Kariyama R; Kumon H; Chow JW
Antimicrob Agents Chemother; 2000 Sep; 44(9):2545-6. PubMed ID: 10952613
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A
J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility profile of Enterococcus faecalis isolated at the Lagos University Teaching Hospital, Nigeria.
Iregbu KC; Ogunsola FT; Odugbemi TO
Niger Postgrad Med J; 2002 Sep; 9(3):125-8. PubMed ID: 12501265
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of Enterococcus faecalis to twelve antibiotics, time-kill assays, and high-level aminoglycoside resistance in a university hospital in Argentina.
Predari SC; Gutiérrez MA; Ribas C; Molinari GS; Santoianni JE
Rev Argent Microbiol; 1991; 23(2):67-78. PubMed ID: 1815269
[TBL] [Abstract][Full Text] [Related]
8. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM;
J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495
[TBL] [Abstract][Full Text] [Related]
9. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
Ramos MC; Grayson ML; Eliopoulos GM; Bayer AS
Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632
[TBL] [Abstract][Full Text] [Related]
10. High dose ampicillin for the treatment of high-level aminoglycoside resistant enterococcal endocarditis.
Jones BL; Ludlam HA; Brown DF
J Antimicrob Chemother; 1994 Apr; 33(4):891-2. PubMed ID: 8056716
[No Abstract] [Full Text] [Related]
11. A case of vancomycin-resistant enterococcal endocarditis.
Brink AJ; van den Ende J; Routier RJ; Devenish L
S Afr Med J; 2000 Nov; 90(11):1113-5. PubMed ID: 11196031
[No Abstract] [Full Text] [Related]
12. Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity.
Miro JM; Cervera C; Garcia-de-la-Maria C; Del Rio A; Armero Y; Mestres CA; Grau JM; Marco F; Moreno A
Scand J Infect Dis; 2008; 40(11-12):968-72. PubMed ID: 18767002
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of the combination ampicillin plus ceftriaxone in the treatment of a case of enterococcal endocarditis due to Enterococcus faecalis highly resistant to gentamicin: efficacy of the "ex vivo" synergism method.
Tascini C; Doria R; Leonildi A; Martinelli C; Menichetti F
J Chemother; 2004 Aug; 16(4):400-3. PubMed ID: 15332717
[TBL] [Abstract][Full Text] [Related]
14. Endocarditis after ciprofloxacin therapy for enterococcal pyelonephritis with bacteremia.
McDonald GR
J Tenn Med Assoc; 1993 Dec; 86(12):527-8. PubMed ID: 8295423
[No Abstract] [Full Text] [Related]
15. [Enterococcal endocarditis, a model of therapeutic difficulty].
Fernández Guerrero ML; Núñez García A
Rev Clin Esp; 1995 Oct; 195 Suppl 4():41-5. PubMed ID: 9441316
[No Abstract] [Full Text] [Related]
16. Increased bactericidal activity as documented by serum bactericidal titers for a triple combination of cell wall active agents against gentamicin-resistant enterococci.
Antony SJ; Matherin P; Stratton C
Scand J Infect Dis; 1995; 27(4):401-3. PubMed ID: 8658079
[TBL] [Abstract][Full Text] [Related]
17. Ampicillin plus ciprofloxacin therapy of experimental endocarditis caused by multidrug-resistant Enterococcus faecium.
Landman D; Quale JM; Mobarakai N; Zaman MM
J Antimicrob Chemother; 1995 Jul; 36(1):253-8. PubMed ID: 8537276
[TBL] [Abstract][Full Text] [Related]
18. Infective endocarditis caused by Enterococcus faecalis treated with continuous infusion of ampicillin without adjunctive aminoglycosides.
Ogawa T; Sato M; Yonekawa S; Nakagawa C; Uno K; Kasahara K; Maeda K; Konishi M; Mikasa K
Intern Med; 2013; 52(10):1131-5. PubMed ID: 23676604
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic resistance among enterococci causing endocarditis in the UK: analysis of isolates referred to a reference laboratory.
Johnson AP; Warner M; Woodford N; Speller DC; Livermore DM
BMJ; 1998 Sep; 317(7159):629-30. PubMed ID: 9727989
[No Abstract] [Full Text] [Related]
20. Endocarditis due to high-level gentamicin-resistant Enterococcus faecalis.
Lee PY; Das SS
Postgrad Med J; 1995 Feb; 71(832):117-9. PubMed ID: 7724425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
